CureBay, a hybrid healthcare platform focused on rural delivery, has secured $21 million in its Series B funding round. The round was led by Bertelsmann India Investments, with participation from Elevar Equity and British International Investment, the UK’s development finance institution and impact investor.
Launched in 2021 and headquartered in Odisha, CureBay operates a network of more than 150 eClinics across Odisha and Chhattisgarh. These eClinics are supported by a trained workforce of over 1,000 Swasthya Mitras, who facilitate access to consultations, diagnostics, pharmacy services, and tertiary care. The platform’s preventive health programme currently serves 90,000 active members with a renewal rate above 60 per cent.
The latest capital infusion will be used to strengthen CureBay’s in-house technology stack, expand into new states including Jharkhand, Bihar, Uttar Pradesh, and Madhya Pradesh, and hire teams to support its next growth phase. The company aims to deploy AI, machine learning, and proprietary algorithms to enhance predictive care and workflow automation tailored for rural healthcare settings.
Priyadarshi Mohapatra, Founder and CEO of CureBay, said, “At CureBay, we are a mission-driven team focused on transforming public health outcomes for every Indian. This is not just a fundraiser—it’s a mandate to build India’s trust infrastructure for rural health. With an active network of 150+ eClinics and 1,000+ Swasthya Mitras, we are solving for Bharat, where a large part of the population still lacks access to dependable care. The capital will help us scale technology, talent, and reach to bring dignified, affordable healthcare to the last mile. CureBay’s model is deeply aligned with national priorities like Ayushman Bharat and the Digital Health Mission, and we are proud to be a tech-enabled partner in public health delivery. This is not just a startup getting funded—it’s a public health movement getting backed.”
Pankaj Makkar, Managing Director of Bertelsmann India Investments, said, “We’re excited to partner with CureBay as it builds a differentiated, ecosystem-driven approach to rural healthcare in India. While most rural solutions remain fragmented, CureBay uniquely delivers the full continuum of care under one platform —seamlessly integrating consultations, diagnostics, pharmacy access, and surgeries through its tech-enabled eClinics and robust partner network. This investment reflects Bertelsmann India’s strong commitment to supporting mission-driven companies that are transforming Bharat, with CureBay making quality healthcare both accessible and affordable for rural communities.”
Jyotsna Krishnan, Managing Partner at Elevar Equity, added, “Curebay has demonstrated that a thoughtfully constructed business model can deliver robust unit economics and contribution margins. On the one hand, they leverage cutting-edge technology and AI, but more importantly, they blend into the local ecosystem to build critical trust on the ground in rural markets through a unique distribution set-up. Entrepreneurial Households in India are keen to pay for quality healthcare, and this is a massive underserved segment. We are glad Elevar’s original investment thesis in 2022 played out well. This round is an important milestone for the company as they continue to build scale in a disciplined manner.”
CureBay’s proprietary platform, built entirely in-house, integrates AI/ML, generative AI, and IoT diagnostics for early detection, personalised care, and operational efficiency. The company recently announced operational profitability for its Balasore and Puri Circles.
The funding round marks a strategic step in CureBay’s plan to deliver integrated rural healthcare aligned with national initiatives and international development goals.
